These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8864138)

  • 1. Role of interferon-gamma in immunity to herpes simplex virus.
    Yu Z; Manickan E; Rouse BT
    J Leukoc Biol; 1996 Oct; 60(4):528-32. PubMed ID: 8864138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM; Wolcott RM; Chervenak R; Jennings SR
    Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice.
    Cantin E; Tanamachi B; Openshaw H; Mann J; Clarke K
    J Virol; 1999 Jun; 73(6):5196-200. PubMed ID: 10233988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection.
    Holterman AX; Rogers K; Edelmann K; Koelle DM; Corey L; Wilson CB
    J Virol; 1999 Mar; 73(3):2058-63. PubMed ID: 9971787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
    Cunningham AL; Noble JR
    J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of ultraviolet irradiation of the skin on herpes simplex virus infection: alteration in immune function mediated by epidermal cells and in the course of infection.
    Otani T; Mori R
    Arch Virol; 1987; 96(1-2):1-15. PubMed ID: 3039943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultraviolet-B irradiation alters cytokine production by immune lymphocytes in herpes simplex virus-infected mice.
    Yasumoto S; Moroi Y; Koga T; Kawamura I; Mitsuyama M; Hori Y
    J Dermatol Sci; 1994 Dec; 8(3):218-23. PubMed ID: 7865481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly I:C-induced anti-herpes simplex virus type 1 activity in inflammatory macrophages is mediated by induction of interferon-beta.
    Pyo S; Gangemi JD; Ghaffar A; Mayer EP
    J Leukoc Biol; 1991 Nov; 50(5):479-87. PubMed ID: 1660913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis.
    Sciammas R; Kodukula P; Tang Q; Hendricks RL; Bluestone JA
    J Exp Med; 1997 Jun; 185(11):1969-75. PubMed ID: 9166426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
    Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response.
    Nash AA; Phelan J; Wildy P
    J Immunol; 1981 Apr; 126(4):1260-2. PubMed ID: 6259256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
    J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.
    Martin S; Cantin E; Rouse BT
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1359-70. PubMed ID: 2543783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID).
    Minagawa H; Sakuma S; Mohri S; Mori R; Watanabe T
    Arch Virol; 1988; 103(1-2):73-82. PubMed ID: 2850780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
    Winter H; Hu HM; McClain K; Urba WJ; Fox BA
    J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57BL/6) strains of mice.
    Brenner GJ; Cohen N; Moynihan JA
    Cell Immunol; 1994 Sep; 157(2):510-24. PubMed ID: 8069930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.